A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/381 (2006.01) A61K 9/00 (2006.01) A61K 47/00 (2006.01)
Patent
CA 2505040
By using a composition comprising rotigotine and at least one chloride salt in a concentration of 1 to 140 mmol/l, the composition having a pH of 4 to 6.5 in a iontophoretic device for the treatment of Parkinson's disease, it became possible to obtain a rotigotine flux across the human stratum corneum which was higher than the one previously obtained with conventional passive diffusion systems.
Le procédé décrit consiste à utiliser une composition contenant de la rotigotine et au moins un sel de chlorure à raison d'une concentration comprise entre 1 et 140 mmol/l, cette composition présentant un pH compris entre 4 et 6,5 dans un dispositif iontophorétique pour le traitement de la maladie de Parkinson. Ce procédé permet d'obtenir un flux de rotigotine à travers la couche cornée qui est plus important que celui obtenu précédemment avec les dispositifs conventionnels à diffusion passive.
Bouwstra Johanna Aaltje
Li Gai Ling
Nugroho Akhmad Kharis
Wolff Hans-Michael
Kirby Eades Gale Baker
Schwarz Pharma Ag
Ucb Pharma Gmbh
LandOfFree
Composition for iontophoretic delivery of rotigotine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for iontophoretic delivery of rotigotine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for iontophoretic delivery of rotigotine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1879584